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B enzodiazepines are known to induce microsei-zures during sleep,  and these microseizures are 
associated with high amplitude fast activities on electro-
encephalography (EEG) [1 , 2]. We report the case of a 
patient with a similar phenomenon during topiramate 
(TPM) administration.  To the best of our knowledge,  
this is the first report of microseizures induced by TPM.
Case Report
The patient was a 22-year-old Japanese male with 
trisomy 21.  He was delivered at term by caesarean sec-
tion because of cephalopelvic disproportion.  Three days 
after birth,  he underwent surgery for duodenal 
obstruction.  A ventricular septal defect was also 
detected but it disappeared spontaneously.  At 1 month 
of age,  he underwent surgery for bilateral cataracts.  
Hypothyroidism was treated using thyroid hormone.  
At 4 months of age,  he was diagnosed with West syn-
drome and received adrenocorticotropic hormone 
(ACTH) therapy.  At 10 years of age,  a gastrostomy was 
performed because of recurrent aspiration pneumonitis.
After the suppression of epileptic spasms using 
ACTH therapy,  his seizure type changed to complex 
partial seizures.  These seizures were accompanied by a 
loud cry and upper deviation of his eyes,  bilateral ele-
vation of the upper arms,  and twisting of his body 
toward the right,  followed by generalized clonic con-
vulsions.  These seizures continued for 1 to 2 min and 
often occurred several times in cluster,  or they devel-
oped into status epilepticus,  lasting for 15 to 30 min.  
These seizures continued to occur approx.  5 × /month.
At 19 years of age,  he was admitted to our facility.  
He was bedridden and had no sign of secondary sex 
characteristics.  His height was 144 cm and weight was 
21 kg.  He was administered antiepileptic drugs consist-
ing of 150-mg zonisamide,  6-mg clobazam,  55-mg 
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A 22-year-old Japanese male with trisomy 21 was diagnosed with West syndrome at 4 months old.  After the 
suppression of epileptic spasms using adrenocorticotropic hormone therapy,  he had complex partial seizures 
and bilateral frontal epileptic discharges on EEG.  Although the introduction of topiramate (TPM) decreased 
the seizures during wakefulness,  frequent episodes of brief eye-opening appeared during sleep while the patient 
was taking TPM (400 mg/day).  EEG showed fast activity at the times of eye-opening.  The episodes of 
eye-opening during sleep and the fast activities disappeared upon TPM discontinuation.  This is the first report 
of TPM-induced microseizures similar to benzodiazepine-induced microseizures.
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lamotrigine,  and 300-mg valproic acid daily.  
Clonazepam,  carbamazepine and a ketogenic diet had 
no effect.
At admission,  a brain computed tomography scan 
showed no gross abnormalities,  and EEG showed bilat-
eral frontal epileptic discharges.  Although we increased 
the dose of lamotrigine from 55 mg to 70 mg per day,  
his seizures continued with the same frequency as 
before.  When we added TPM and increased its dose to 
100 mg,  the seizure frequency dramatically decreased 
to 1 × /month.  At a daily dose of 150 mg TPM and a 
blood level 6.1 μg/ml measured at 21 years 6 months 
old,  another EEG examination showed bilateral frontal 
epileptic discharges with left frontal dominance,  as 
before (Fig. 1).  However,  soon thereafter the seizure 
frequency again increased to 12-15 × /month.  We then 
added levetiracetam,  and increased its dose to 
1,750 mg (76 mg/kg/day),  and the seizure frequency 
decreased to 4 × /month.  Because TPM seemed to be 
effective temporarily and its dose had not reached the 
maximum level,  we increased the TPM dose to 400 mg 
and observed a blood level of 21.6 μg/ml.  The seizure 
frequency again decreased to 1 × /month.
Another EEG examination revealed approx.  50 μV,  
diffuse fast activities (12-14 c/sec) frequently appearing 
during sleep in addition to bilateral frontal and occipital 
epileptic discharges.  These fast activities occurred 
29 times during the EEG examination while the patient 
was asleep,  and 13 of the 29 fast activities were accom-
panied by brief eye-opening (Fig. 2).  These episodes 
resembled the reported microseizures induced by ben-
zodiazepines in their clinical and EEG manifestations 
and also in their mode of appearance.  We thus sus-
pected that these microseizures might be induced by 
TPM,  and we discontinued the TPM.  Two months 
after the discontinuation,  diffuse fast activities had dis-
appeared on EEG,  although bilateral frontal epileptic 
discharges remained.  The microseizures during sleep 
also disappeared,  but the seizure frequency during 
wakefulness increased to the level before the introduc-
tion of TPM.  We therefore increased the daily dose of 
zonisamide to 300 mg and added perampanel 6 mg per 
day.
Discussion
Ohtahara et al.  reported newly recognized microsei-
zures that appeared to be related to the increase in the 
benzodiazepine dose in 21 patients with Lennox-Gastaut 
syndrome,  in 1982 [1] and 1983 [2].  The main clinical 
symptoms were opening the eyes and respiratory sup-
pression during sleep,  and ictal EEGs showed peculiar 
bursts of hypersynchronous rapid activities (8-18 Hz).  
Because these microseizures were suppressed by the 
decrease or discontinuation of benzodiazepines,  those 
authors concluded that the microseizures were induced 
by benzodiazepines.
The ictal clinical and EEG manifestations observed 
in our patient were similar to these previously reported 
benzodiazepine-induced microseizures.  His microsei-
zures appeared with an increase in the TPM dose and 
disappeared when the TPM was discontinued.  We thus 
suspected that our patient’s microseizures were induced 
by TPM.  On the other hand,  there is a possibility that 
concomitant antiepileptic drugs other than TPM,  espe-
cially clobazam (a type of benzodiazepine),  might have 
had some influence on the occurrence of his microsei-
zures.  To evaluate the changes in the blood level of each 
antiepileptic drug,  we analyzed the patient’s blood 
levels before and after the increase in TPM dosage.  We 
found no increase in the blood levels of clobazam or 
N-desmethylclobazam (Table 1).  Accordingly,  we con-
cluded that the main cause of our patient’s microsei-
zures was the increase in the dosage and blood levels of 
TPM.
Comparing benzodiazepine-induced microseizures 
and TPM-induced microseizures,  TPM-induced 
microseizures were observed in a patient with frontal 
lobe epilepsy,  while benzodiazepine-induced microsei-
zures were observed in those with Lennox-Gastaut syn-
drome.  For ictal EEGs,  amplitude has tended to be 
higher in benzodiazepine-induced microseizures.  TPM-
induced microseizures appeared mainly during sleep 
stage 1,  whereas benzodiazepine-induced microsei-
zures appeared mainly during sleep stage 2 or thereafter.
Common characteristics of benzodiazepine-induced 
microseizures and TPM-induced seizures are that they 
appeared exclusively during sleep and were associated 
with newly appearing peculiar fast activities,  whereas 
the original seizures during wakefulness dramatically 
decreased in our patient with TPM-induced maicrosei-
zures and those with benzodiazepine-induced microsei-
zures.  We suggest that these two types of microseizures 
might have some common mechanisms of occurrence.  
Yagi et al.  reported mild clinical attacks manifested 
alongside a high-voltage spike discharge during sleep in 
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Fig. 1　 Interictal EEG during the patientʼs sleep at age 21 years 6 months.  The EEG shows bilateral frontal spikes,  predominantly at the 
left frontal pole.  Characteristic fast activities (Fig.2) were not observed on this EEG. The plasma TPM concentration was 6.1 μg/ml.
Fig. 2　 Ictal EEG of a microseizure induced by TPM.  The EEG shows diﬀuse fast activity during light sleep,  which was associated with 
eye-opening.  The plasma TPM concentration was 21.6 μg/ml.
patients with Lennox-Gastaut syndrome [3].  Brenner et 
al.  reported similar generalized paroxysmal fast activity 
in epileptic patients,  mostly those with Lennox-Gastaut 
syndrome [4].  These previously reported seizures or 
characteristic EEG activities might be the same phe-
nomenon as that underlying benzodiazepine-induced 
microseizures in Lennox-Gastaut syndrome.
Mesencephalic reticular formation and thalamic 
reticular formation are believed to play a critical role in 
the pathophysiology of Lennox-Gastaut syndrome.  
These structures are also closely related to sleep mecha-
nisms.  One of the main effects of benzodiazepines is a 
hypnotic effect; benzodiazepines may thus provoke 
characteristic microseizures by influencing sleep mech-
anisms.  
A similar phenomenon might have been induced by 
TPM in our patient with frontal lobe epilepsy.  He has a 
history of West syndrome,  which belongs to age-de-
pendent epileptic encephalopathies consisting of 
Ohtahara syndrome,  West syndrome,  and Lennox-
Gastaut syndrome [5 , 6].  A transition from West syn-
drome to Lennox-Gastaut syndrome with age is often 
observed,  and both epileptic syndrome share the com-
mon pathophysiological characteristics of corticoretic-
ular epilepsy.  Although our patient manifested frontal 
lobe epilepsy after West syndrome,  an epileptogenic 
pathophysiology similar to Lennox-Gastaut syndrome 
might have continued after the suppression of West syn-
drome.
At a TPM serum concentration of 6.1 μg/ml,  there 
were neither characteristic fast EEG activities nor 
microseizures which consisted of brief eye-opening 
during sleep.
The therapeutic range of the TPM blood level is con-
sidered to be from 2 to 25 μg/ml [7],  but a blood level 
> 25 μg/ml might sometimes be necessary.  Because the 
microseizures in our patient appeared at a TPM blood 
level of 21.6 μg/ml,  careful monitoring of the appear-
ance of microseizures associated with characteristic fast 
activities on EEG may be needed during TPM therapy,  
especially during high-dose therapy.
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Table 1　 Blood levels of antiepileptic drugs before and after appearance of microseizures
Antiepileptic drugs Daily dose (blood level) Daily dose (blood level)
TPM 200 mg (12.4 μg/ml) 400 mg (21.6 μg/ml)
VPA 300 mg (72 μg/ml) 300 mg (43 μg/ml)
ZNS 150 mg (9.3 μg/ml) 150 mg (7.2 μg/ml)
LTG 70 mg (5.4 μg/ml) 70 mg (4.4 μg/ml)
LEV 1,750 mg (55.4 μg/ml) 1,750 mg (56.7 μg/ml)
CLB 6 mg (129 ng/ml) 6 mg (81 ng/ml)
desmethylCLB (816 ng/ml) (704 ng/ml)
TPM: topiramate,  VPA: valproic acid,  ZNS: zonisamide,  LTG: lamotrigine,  LEV: levetiracetam,  CLB: clobazam
